Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico

Arredondo, Armando; Zuñiga, Alexis; Parada, Irene

doi:10.1016/j.puhe.2005.01.009

Cited by 32 publications

(29 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is projected that the combined financial requirements for the treatment of DM and HTN in 2006 will amount to 9.5% of the total budget for the uninsured and 13.5% for the insured populations. [20] In conclusion, cardiovascular risks factors are highly common among the Mexican population and increasing at alarming rates. They represent the main leading causes of morbidity and mortality in our country.…”

Section: Discussionmentioning

confidence: 97%

“…In the three main public institutions of the country,s health care system, the total expenditures diabetes in 2005 have been estimated at USD $317,631,206, including USD $140,410,816 in direct costs and USD $177,220,390 in indirect costs, a 26% increase from 2003. [19] To cover the service demand by diabetic patients, the [20] It has been pointed out that the prevalence of DM in Mexico will increase drastically over the next decades for a number of reasons. [21] First, obesity, which is a risk factor for type 2 DM, is increasing rapidly in Mexico.…”

Section: Diabetes Mellitusmentioning

confidence: 99%

“…It is expected that the combined financial requirements for the treatment of DM and HTN in 2006 will amount 9.5% of the total budget for the uninsured (SSA) population and 13.5% for the insured (IMSS, ISSSTE) population. [20] …”

Section: Arterial Hypertensionmentioning

confidence: 99%

See 2 more Smart Citations

Cardiovascular Risk Factors in the Mexican Population

et al. 2006

View full text Add to dashboard Cite

Chronic degenerative disorders have become a major health problem in Mexico. Cardiovascular diseases represent the first cause of death in our country. Diabetes mellitus (DM) has emerged as the main health problem in Mexico. Its prevalence doubled from < 3% in the 1960s to 6% in the 1980s. Between 1993 and 2000, diabetes mellitus increased from 6.7% to 8.2%, a 22% growth over a seven-year period. In 1995, the cost of the treatment of DM represented 15.48% of the health budget and 0.79% of the GDP. The prevalence of hypertension (HTN) increased from 10% in 1933 to 20% in 1990 and from 23.8% to 30.7% between 1993 and 2000. The expenditures from HTN in 1999 corresponded to 13.9% of the health budget, and 0.71% of GDP.Dyslipidemias are very common. Close to 40% of the population has levels of HDL cholesterol < 35 mg/dL, 24.3% has fasting triglycerides > 200 mg/dL, and 10% has hypercholesterolemia. The prevalence of obesity increased from 21.4% in 1993, to 23.7% in the year 2000. Eight percent of the population has a glomerular filtration rate < 60 mL/min, and 9.1% has proteinuria. Twenty-four percent uses tobacco regularly, and 13% had the habit in the past. Smoking is more frequent among diabetics (34%).In conclusion, cardiovascular risks factors are highly common among the Mexican population and increasing at alarming rates. Preventive programs targeted to decrease their prevalence are urgently needed in Mexico and should become a national priority.

show abstract

Section: Discussionmentioning

confidence: 97%

Section: Diabetes Mellitusmentioning

confidence: 99%

See 1 more Smart Citation

Cardiovascular Risk Factors in the Mexican Population

et al. 2006

View full text Add to dashboard Cite

show abstract

“…México tendría que enfrentarse a un aumento anual del gasto en salud de entre el 5 y el 7% (Arredondo et al 2005). Cifras igual de preocupantes son citadas por Glassman y colegas para el caso de Brasil, en donde se señala que de mantenerse las actuales tendencias en las prevalencias de enfermedades crónicas, el gasto de atención en salud en Brasil podría duplicarse al pasar de 20 billones de reales a 45 billones en los próximos 40 años.…”

unclassified

Nota 1: Introducción: Serie de notas técnicas sobre procesos de priorización en salud

Giedión¹,

Muñoz²,

Ávila³

2015

View full text Add to dashboard Cite

“…Estudos de estimativa do custo anual associado à atenção aos portadores de diabetes melito nos Estados Unidos e na América Latina revelaram que os custos diretos e indiretos totalizaram US$ 102,5 e US$ 94,3 bilhões, respectivamente (5,9). Análises de custo do tratamento para o diabetes em países latino-americanos demonstraram a significante carga econômica da doença para os sistemas de saúde e sociedade (10)(11)(12).…”

unclassified

Análise de custos da assistência à saúde aos portadores de diabetes melito e hipertensão arterial em uma unidade de saúde pública de referência em Recife - Brasil

Marinho

Cesse

Bezerra

et al. 2011

Arq Bras Endocrinol Metab

View full text Add to dashboard Cite

OBJETIVO: Analisar os custos para a assistência à saúde de portadores de diabetes melito e hipertensão arterial e estimar o custo de procedimentos ambulatoriais de média complexidade comparando-os com os valores da tabela de reembolso do Sistema Único de Saúde (SUS). MATERIAIS E MÉTODOS: Foram analisados os custos diretos sanitários, em unidade pública de referência em Recife/PE no ano de 2007. Para o levantamento e alocação dos custos, utilizaram-se as técnicas de custeio por absorção e de rateio. RESULTADOS: Os custos diretos e o valor reembolsado pelo SUS totalizaram R$ 4.855.291,82 e R$ 2.118.893,56, respectivamente. Os grupos de despesas que apresentaram maiores custos foram: medicamentos R$ 1.762.424,42 (36,3%), serviços de terceiros R$ 996.637,82 (20,5%) e pessoal R$ 978.096,10 (20,1%). Todos os procedimentos apresentaram maior custo estimado que os valores pagos pela tabela SUS. CONCLUSÕES: Os medicamentos representaram os maiores custos para assistência e identificou-se diferença considerável entre os custos estimados e os valores reembolsados pelo SUS.

show abstract

Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico

Cited by 32 publications

References 14 publications

Cardiovascular Risk Factors in the Mexican Population

Cardiovascular Risk Factors in the Mexican Population

Nota 1: Introducción: Serie de notas técnicas sobre procesos de priorización en salud

Análise de custos da assistência à saúde aos portadores de diabetes melito e hipertensão arterial em uma unidade de saúde pública de referência em Recife - Brasil

Contact Info

Product

Resources

About